EUVIMEDEUVIMED entdecken
Crossref

Reactive Oxygen Species-Responsive Nanoparticle Delivery of Small Interfering Ribonucleic Acid Targeting Olfactory Receptor 2 for Atherosclerosis Theranostics

Huaner Ni, Hui Zhou iD, Xin Liang, Yulong Ge, Hangwei Chen, Junyi Liu, Ben Wang, Huiyu Chen, Yujing Zhang, Sihan Luo, Ying Chen, Xiaomei Lu und 2 weitere

ACS Nano · 27.08.2024 · 18 (34) · 23599-23614

DOI: 10.1021/acsnano.4c07988 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 14.08.2024. Verfasst von Huaner Ni und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organic Electronics and Information Displays & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommu…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, RNA, Small Interfering, Theranostic Nanomedicine, Atherosclerosis. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Jiangsu Provincial Department of Education, Natural Science Foundation of Jiangsu Province, Nanjing University of Posts and Telecommunications.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis (AS) is a chronic inflammatory disorder characterized by arterial intimal lipid plaques. Small interfering ribonucleic acid (siRNA)-based therapies, with their ability to suppress specific genes with high targeting precision and minimal side effects, have shown great potential for AS treatment. However, targets of siRNA therapies based on macrophages for AS treatment are still limited. Olfactory receptor 2 (Olfr2), a potential target for plaque formation, was discovered recently. Herein, anti-Olfr2 siRNA (si-Olfr2) targeting macrophages was designed, and the theranostic platform encapsulating si-Olfr2 to target macrophages within atherosclerotic lesions was also developed, with the aim of downregulating Olfr2, as well as diagnosing AS through photoacoustic imaging (PAI) in the second near-infrared (NIR-II) window with high resolution. By utilization of a reactive oxygen species (ROS)-responsive nanocarrier system, the expression of Olfr2 on macrophages within atherosclerotic plaques was effectively downregulated, leading to the inhibition of NLR family pyrin domain containing 3 (NLRP3) inflammasome activation and interleukin-1 β (IL-1β) secretion, thereby reducing the formation of atherosclerotic plaques. As manifested by decreased Olfr2 expression, the lesions exhibited a significantly alleviated inflammatory response that led to reduced lipid deposition, macrophage apoptosis, and a noticeable decrease in the necrotic areas. This study provides a proof of concept for evaluating the theranostic nanoplatform to specifically deliver si-Olfr2 to lesional macrophages for AS diagnosis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesRNA, Small InterferingTheranostic NanomedicineAtherosclerosisNanoparticlesAnimalsMiceReceptors, OdorantMacrophagesRAW 264.7 CellsHumansMice, Inbred C57BLNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesPlaque, Atherosclerotic

Stichwörter der Autor:innen

NIR-II PAIOlfr2atherosclerosis treatmentsiRNA deliverytheranostics

Substanzen

Reactive Oxygen SpeciesRNA, Small InterferingReceptors, OdorantNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomes

Autor:innen und Institutionen

  • State Key Laboratory of Organic Electronics and Information Displays & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, Nanjing 210023, China.
  • Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
  • Key Laboratory of Flexible Electronics (KLOFE), Institute of Advanced Materials (IAM) & School of Flexible Electronics (Future Technologies), Nanjing Tech University, 30 South Puzhu Road, Nanjing 211816, China.
  • Zhengzhou Institute of Biomedical Engineering and Technology, Zhengzhou 450001, China.

ORCID-Profile: Hui Zhou, Chao Yin, Quli Fan

Förderung

  • Jiangsu Provincial Department of Education
  • Natural Science Foundation of Jiangsu Province
  • Nanjing University of Posts and Telecommunications
  • Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions
  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Ni, H., Zhou, H., Liang, X., Ge, Y., Chen, H., Liu, J., Wang, B., Chen, H., Zhang, Y., Luo, S., Chen, Y., Lu, X., Yin, C., & Fan, Q. (2024). Reactive Oxygen Species-Responsive Nanoparticle Delivery of Small Interfering Ribonucleic Acid Targeting Olfactory Receptor 2 for Atherosclerosis Theranostics. ACS Nano, 18(34), 23599-23614. https://doi.org/10.1021/acsnano.4c07988

Vancouver

Ni H, Zhou H, Liang X, Ge Y, Chen H, Liu J, et al. Reactive Oxygen Species-Responsive Nanoparticle Delivery of Small Interfering Ribonucleic Acid Targeting Olfactory Receptor 2 for Atherosclerosis Theranostics. ACS Nano. 2024;18(34):23599-23614. doi:10.1021/acsnano.4c07988

BibTeX
@article{Ni2024,
  author = {Ni, Huaner and Zhou, Hui and Liang, Xin and Ge, Yulong and Chen, Hangwei and Liu, Junyi and Wang, Ben and Chen, Huiyu and Zhang, Yujing and Luo, Sihan and Chen, Ying and Lu, Xiaomei and Yin, Chao and Fan, Quli},
  title = {Reactive Oxygen Species-Responsive Nanoparticle Delivery of Small Interfering Ribonucleic Acid Targeting Olfactory Receptor 2 for Atherosclerosis Theranostics},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {34},
  pages = {23599--23614},
  doi = {10.1021/acsnano.4c07988}
}
Kostenlos starten →